9/23/2014. Genetics knowledge in cardiology is developing rapidly. Professional recommendations support cardiac genetic testing

Size: px
Start display at page:

Download "9/23/2014. Genetics knowledge in cardiology is developing rapidly. Professional recommendations support cardiac genetic testing"

Transcription

1 How Does Family History Influence Psychosocial Adaptation in Individuals with Inherited Cardiomyopathies and their At-risk Family Members? Cynthia A. James, ScM, PhD, CGC Johns Hopkins ARVD/C Program, Division of Cardiology Jane Engelberg Memorial Fellowship Presentation, 2014 NSGC Annual Education Conference September 19, Genetics knowledge in cardiology is developing rapidly A 19 mm B 13 mm A B = 1μm 2 Professional recommendations support cardiac genetic testing 3 1

2 Genetic counseling recommended 4 Knowledge base to inform our practice is lacking Patients have significant adaptation difficulties Ability to identify patients at high risk for clinically significant distress is limited Ability to understand mechanism by which patients and families adapt or fail to adapt 5 Preliminary data: Family history was associated with LESS anxiety Variable Interval OR (PI) p Value Age 1 year older.96 (.91,.02) 0.10 Family History Yes.24 (.06,.88) 0.00 DASI 1 point.95 (.91,.996) 0.03 # of ICD Shocks 1 shock.98(.94, 1) 0.23 Controlling for age, functional capacity and arrhythmic history, individuals with positive family history = LESS likely to have clinically significant anxiety. Study of 86 adults with ARVC and an ICD (Jamal et al, 2012) 6 2

3 Preliminary data: Family history was associated with LESS depression In this sample 8 (9%) of participants met the HADS-D criteria for clinical depression (HADS-D 8). None had a known family history of ARVC. Study of 86 adults with ARVC and an ICD (Jamal et al, 2012) 7 Adaptation Facilitating adaptation to the medical, psychological, and familial implications of disease is part of the definition of genetic counseling. Adaptation can be defined as the process and outcomes of coming to terms with the implications of a health threat. It is a multidimensional concept typically including absence of psychological disorder, low negative affect, achievement of illness-related activities, and appraisals of well-being 8 Wallander s Risk and Resistance Model of Psychosocial Adjustment in Chronic Illness Emphasis on the modulating effect of resistance factors on the relationship between disease-specific risk factors and inter- and intrapersonal resistance factors. Chosen because a primary goal is to investigate how family history may influence resistance to adaptation difficulties 9 3

4 Study aims 1) Confirm preliminary evidence that a positive family history of disease is associated with lower anxiety and depression in ARVC and investigate the mechanism through which this protective influence operates. 2) Determine whether family history is associated with lower rates of anxiety and depression in HCM. 3) Identify other factors that affect adaptation to ARVC and HCM among affected individuals and at-risk family members. 4) Conduct an in-depth analysis of how a subset of affected individuals and at-risk family members perceive the influence of family history via interviews. 10 Study design Phase 1 (Aims 1-3) Administration of a cross-sectional questionnaire of up to 800 affected and at-risk adults in the Johns Hopkins ARVC and HCM Registries Phase 2 (Aim 4) Semi-structured telephone interviews of 30 survey participants to assess how individuals perceive impact of family history on adaptation 11 Population Adults Enrolled in the Johns Hopkins Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) or Hypertrophic Cardiomyopathy (HCM) research registries: Current clinical diagnosis OR At-risk for developing ARVC / HCM due to mutation status and/or family history. 12 4

5 ARVC and HCM Inherited cardiomyopathies with incomplete penetrance and variable expressivity ARVC Prevalance 1/5000 Mutations primarily in desmosomal genes identifiable in up to 60% Frequent ventricular arrhythmias / high risk of sudden death Placement of implantable defibrillators with frequent shocks common. HCM Prevalance 1/500 Mutations primarily in sarcomere genes in up to 60-70% Ventricular arrhythmias / high risk of SCD Atrial fibrillation Heart failure Surgical treatment 13 Wallander s Risk and Resistance Model of Psychosocial Adjustment in Chronic Illness Model informed selection of measures used in questionnaire: Risk factors Resistance factors Adaptation (adjustment) 14 Questionnaire measures Risk factors Disease factors Genotype Phenotype Family history Functional capacity Duke Activity Status Index (DASI) 12-item instrument designed for use with cardiac patients. Psychosocial stressors ICD implant ICD shock Surgical procedures 15 5

6 Questionnaire Measures Resistance factors Social (familial) factors Family APGAR perception of family support and functioning Subscales: Adaptability, partnership, growth, affection, resolve Stress processing Florida Patient Acceptance Survey ICD perceptions 16 Questionnaire Measures Adaptation Clinically significant anxiety and depression HADS Heart-focused anxiety Cardiac Anxiety Questionnaire - validated in both patients and family members Adaptation to genetic disease in the family Psychological Adaptation Scale Subscales (social integration, self-esteem, positive stress response, spiritual/existential impact) Validated in six separate studies of adults with a variety of genetic conditions and caregivers of children with genetic conditions. 17 Hypotheses to be tested H1: Having multiple affected individuals in a family improves mutual social support between family members H2: Familiarity with the disease via other family members may prime coping responses and provide buffering against psychological distress. 18 6

7 Qualitative exploration and validation (Aim 4) Guided by questionnaire results we will develop a semi-structured interview guide Telephone interviews with 30 survey respondents Qualitative analysis - interviews transcribed, double coded 19 Timeline 20 Advisory committee Samuel F. Sears, PhD Crystal Tichnell, MGC Lori Erby, PhD, CGC Hugh Calkins, MD Brittney Murray, MS, CGC Theodore Abraham, MD 21 7

JOHNS HOPKINS ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY PROGRAM

JOHNS HOPKINS ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY PROGRAM JOHNS HOPKINS ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY PROGRAM Volume 5, Issue 2 Summer 2015 2015 ARVD/C Family Seminar Keep Calm and Carry On! That was the theme for seminar weekend!

More information

Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology

Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology Update on use of cardiac MRI in ARVC/D Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology Outline Background Diagnosis Characteristic imaging findings Genetics of ARVC Genotype phenotype

More information

Silvia G Priori MD PhD

Silvia G Priori MD PhD The approach to the cardiac arrest survivor Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular Genetics

More information

SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM

SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM Rio De Janeiro 2016 Sport and Exercise Cardiology Symposium SBC/SOCERJ ACC Sharlene M. Day, MD Associate Professor, Cardiovascular Medicine Director,

More information

Plotse hartdood & genetica

Plotse hartdood & genetica Onder spanning inspannen Utrecht, 17 April 2018 Plotse hartdood & genetica N. Hofman, PhD Academic Medical Centre Amsterdam, the Netherlands European Reference Network Network of centres in Europe sharing

More information

Risk prediction in inherited conditions Laminopathies

Risk prediction in inherited conditions Laminopathies Risk prediction in inherited conditions Laminopathies Karim Wahbi Cochin hospital, Paris karim.wahbi@aphp.fr Risk prediction in laminopathies Current approach for risk stratification A new score to predict

More information

ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON

ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON EUROPACE 2011 INHERITED ELECTRICAL CARDIAC DISORDERS ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON June 26 th 2011 Robert Lemery MD CONFLICTS of INTEREST None ASYMPTOMATIC ARVC 1. ECG 2. ASYMPTOMATIC PVC

More information

EPICARDIAL ABLATION IN GENETIC CARDIOMYOPATHIES: A NEW FRONTIER

EPICARDIAL ABLATION IN GENETIC CARDIOMYOPATHIES: A NEW FRONTIER EPICARDIAL ABLATION IN GENETIC CARDIOMYOPATHIES: A NEW FRONTIER C. Pappone, M. M. Monasky, G. Ciconte Arrhythmology and Electrophysiology Department, IRCCS Policlinico San Donato, San Donato Milanese,

More information

DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong

DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong APHRS Summit 2018 in conjunction with HKCC Heart Rhythm Refresher Course DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the

More information

Clinical aspects of Arrhythmogenic Cardiomyopathies

Clinical aspects of Arrhythmogenic Cardiomyopathies Clinical aspects of Arrhythmogenic Cardiomyopathies INTERNATIONAL CLINICAL CARDIOVASCULAR GENETICS CONFERENCE 25 May 2018 Dr Hari Raju MBChB PhD ECES FRACP Clinical Associate Professor, Macquarie University,

More information

LIVING WITH AND IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR; IT S MORE THAN A SHOCK Perceived control and quality of life

LIVING WITH AND IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR; IT S MORE THAN A SHOCK Perceived control and quality of life LIVING WITH AND IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR; IT S MORE THAN A SHOCK Perceived control and quality of life BENGT FRIDLUND, RNT PHD FESC PROFESSOR, DIRECTOR JÖNKÖPING UNIVERSITY, SWEDEN BENGT.FRIDLUND@HHJ.HJ.SE

More information

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A AEDs. See Automated external defibrillators (AEDs) AF. See Atrial fibrillation (AF) Age as factor in SD in marathon runners, 45 Antiarrhythmic

More information

Psychiatric aspects of patients with the ICD. Post Implantable Defibrillator Shock Psychology Counselling

Psychiatric aspects of patients with the ICD. Post Implantable Defibrillator Shock Psychology Counselling Psychiatric aspects of patients with the ICD Post Implantable Defibrillator Shock Psychology Counselling Brian Baker Department of Psychiatry, University Health Network and University of Toronto Trajectory

More information

Citation for published version (APA): Christiaans, I. (2010). Hypertrophic cardiomyopathy: towards an optimal strategy

Citation for published version (APA): Christiaans, I. (2010). Hypertrophic cardiomyopathy: towards an optimal strategy UvA-DARE (Digital Academic Repository) Hypertrophic cardiomyopathy: towards an optimal strategy Christiaans, I. Link to publication Citation for published version (APA): Christiaans, I. (2010). Hypertrophic

More information

Mahmoud Suleiman MD. On behalf of the Israeli ICD Registry Scientific Committee. Jan 11, National ICD Registry

Mahmoud Suleiman MD. On behalf of the Israeli ICD Registry Scientific Committee. Jan 11, National ICD Registry The Israeli ICD Registry- Update Mahmoud Suleiman MD On behalf of the Israeli ICD Registry Scientific Committee Jan 11, 2013 Jul 2010-Dec 2012 Total Number of Procedures N=5280 New Implants N=3448 Generator

More information

Deactivating implantable cardiac defibrillators in end of life care. Dr Laurence O Toole Consultant Cardiologist STH NHS FT 20 th November 2014

Deactivating implantable cardiac defibrillators in end of life care. Dr Laurence O Toole Consultant Cardiologist STH NHS FT 20 th November 2014 Deactivating implantable cardiac defibrillators in end of life care Dr Laurence O Toole Consultant Cardiologist STH NHS FT 20 th November 2014 Implantable Cardiac Defibrillators (ICDs) ICDs have 3 main

More information

ESSENTIAL MESSAGES FROM ESC GUIDELINES

ESSENTIAL MESSAGES FROM ESC GUIDELINES ESSENTIAL MESSAGES FROM ESC GUIDELINES Committee for Practice Guidelines To improve the quality of clinical practice and patient care in Europe HCM GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC

More information

HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW?

HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW? HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW? Division of Inherited Cardiac Diseases Heart Center for the Young and Athletes A Dpt of Cardiology University of Athens LANCET 2013 ESC HCM

More information

A patient with heart failure and resynchronisation/ about training and exercise?

A patient with heart failure and resynchronisation/ about training and exercise? A patient with heart failure and resynchronisation/ ICD: what is specific about training and exercise? Jean-Paul Schmid, MD Cardiovascular Prevention & Rehabilitation Division of Cardiology University

More information

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex Investigating the family after a sudden cardiac death Dr Catherine Mercer Consultant Clinical Geneticist, Wessex Sudden adult deaths subdivided Sudden Adult Death Sudden Cardiac Death Sudden Arrhythmic

More information

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases Hereditary Cardiovascular Conditions genetic testing for undiagnosed diseases What is Hypertrophic Cardiomyopathy (HCM)? normal heart heart with hcm Extra or thick heart muscle Typically in the left ventricle

More information

Psychological Stress and Disease: Implications for the Gulf Oil Spill. Sheldon Cohen, PhD Carnegie Mellon University

Psychological Stress and Disease: Implications for the Gulf Oil Spill. Sheldon Cohen, PhD Carnegie Mellon University Psychological Stress and Disease: Implications for the Gulf Oil Spill Sheldon Cohen, PhD Carnegie Mellon University How does stress get under the skin? What do we know about stress and health that will

More information

2018 ESC Guidelines for the diagnosis and management of syncope

2018 ESC Guidelines for the diagnosis and management of syncope 2018 ESC Guidelines for the diagnosis and management of syncope Michele Brignole (Chairperson) (Italy); Angel Moya (Co-chairperson) (Spain); Jean-Claude Deharo (France); Frederik de Lange (The Netherlands);

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review

More information

Genetic testing in Cardiomyopathies

Genetic testing in Cardiomyopathies Genetic testing in Cardiomyopathies Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University School of Medicine, New York, USA and Molecular Cardiology, IRCCS Fondazione

More information

EKG screening in athletics

EKG screening in athletics Use of PPE EKG screening in athletics Stefan Montgomery MD, ATC 4/27/18 The overall role of the preparticipation physical evaluation (PPE) is to evaluate the health of the athlete to optimize safe sports

More information

Secondary prevention of sudden cardiac death

Secondary prevention of sudden cardiac death Secondary prevention of sudden cardiac death Balbir Singh, MD, DM; Lakshmi N. Kottu, MBBS, Dip Card, PGPCard Department of Cardiology, Medanta Medcity Hospital, Gurgaon, India Abstract All randomised secondary

More information

Psychology of Mortality

Psychology of Mortality Living with the Risk of Sudden Death: Psychology of Mortality Adrienne H. Kovacs, PhD Portland, Oregon, USA With colleagues and patients we can talk about: Risk stratification for sudden death The use

More information

Royal College of Surgeons in Ireland Annette Burns Royal College of Surgeons in Ireland

Royal College of Surgeons in Ireland Annette Burns Royal College of Surgeons in Ireland Royal College of Surgeons in Ireland e-publications@rcsi Psychology Reports Department of Psychology 1-1-2015 Scoping Review of Experience of People living with Inherited Cardiac Conditions and Congenital

More information

Historical Perspectives on the Implantable Cardioverter Defibrillator and Prevention of Sudden Death in Hypertrophic Cardiomyopathy 165

Historical Perspectives on the Implantable Cardioverter Defibrillator and Prevention of Sudden Death in Hypertrophic Cardiomyopathy 165 Arrhythmias in Cardiomyopathies Foreword: Arrhythmias in Cardiomyopathies Ranjan K. Thakur and Andrea Natale xiii Preface: Arrhythmias in Cardiomyopathies Mohammad Shenasa, Mark S. Link, and Martin S.

More information

Clinical Genetics in Cardiomyopathies

Clinical Genetics in Cardiomyopathies Clinical Genetics in Cardiomyopathies Γεώργιος Κ Ευθυμιάδης Αναπληρωτής Καθηγητής Καρδιολογίας ΑΠΘ No conflict of interest Genetic terms Proband: The first individual diagnosed in a family Mutation: A

More information

What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment. Andreas Pflaumer

What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment. Andreas Pflaumer What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment Andreas Pflaumer Diagnosis of CPVT Induction of different types of VES or VT by exercise or catecholamines AND exclusion of of other

More information

The Hypertrophic Cardiomyopathy (HCM) Center

The Hypertrophic Cardiomyopathy (HCM) Center The Hypertrophic Cardiomyopathy (HCM) Center Comprehensive HCM management from a team you can trust An internationally recognized Center of Excellence in the diagnosis and treatment of HCM The most advanced

More information

Prognostic Importance of Defibrillator Shock

Prognostic Importance of Defibrillator Shock Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/prognostic-importance-of-defibrillator-shock/3680/

More information

Πρόληψη αιφνιδίου καρδιακού θανάτου στους αθλητές

Πρόληψη αιφνιδίου καρδιακού θανάτου στους αθλητές Πρόληψη αιφνιδίου καρδιακού θανάτου στους αθλητές Σωκράτης Παστρωμάς Επιμελητής Α Τμήμα Ηλεκτροφυσιολογίας & Βηματοδότησης Ερρίκος Ντυνάν Hospital Center Pheidippides sudden cardiac death in the Atheneum

More information

Heart Rhythm Disorders. How do you quantify risk?

Heart Rhythm Disorders. How do you quantify risk? Heart Rhythm Disorders How do you quantify risk? Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life.

More information

Left ventricular non-compaction: the New Cardiomyopathy on the Block

Left ventricular non-compaction: the New Cardiomyopathy on the Block Left ventricular non-compaction: the New Cardiomyopathy on the Block Aamir Jeewa MB BCh, FAAP, FRCPC Section Head, Cardiomyopathy & Heart Function Program The Hospital for Sick Children Assistant Professor

More information

New scientific documents from EHRA Management of patients with defibrillator shocks

New scientific documents from EHRA Management of patients with defibrillator shocks New scientific documents from EHRA Management of patients with defibrillator shocks Frieder Braunschweig MD PhD FESC Karolinska University Hospital Stockholm, Sweden Evolution of ICD therapy Worldwide

More information

Specialised Services Policy Position PP151

Specialised Services Policy Position PP151 Specialised Services Policy Position PP151 Complex Devices: Implantable Cardioverter Defibrillators and Cardiac Resynchronisation Therapy for arrhythmias and heart failure January 2019 Version 1.0 Document

More information

What s new in Hypertrophic Cardiomyopathy?

What s new in Hypertrophic Cardiomyopathy? What s new in Hypertrophic Cardiomyopathy? Dr Andris Ellims HCM Clinic @ The Alfred Hypertrophic Cardiomyopathy = otherwise unexplained LV hypertrophy* 1 in 500 prevalence most common inherited cardiovascular

More information

ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director

ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director December 2018 ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director To obtain best results Select Slide Show from the ribbon at the top of your PowerPoint screen Select From Beginning on the

More information

Asymptomatic Long QT. Prof. Dr. Martin Borggrefe Mannheim

Asymptomatic Long QT. Prof. Dr. Martin Borggrefe Mannheim Asymptomatic Long QT Prof. Dr. Martin Borggrefe Mannheim QT interval Distribution of QTc intervals in large population-based studies Viskin S, Heart Rhythm 2009; 6: 711-715 QT interval Distribution of

More information

NHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006

NHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006 NHS National Institute for Health and Clinical Excellence Issue date: January 2006 Implantable cardioverter defibrillators (ICDs) for arrhythmias Understanding NICE guidance information for people with

More information

ICD THERAPIES: are they harmful or just high risk markers?

ICD THERAPIES: are they harmful or just high risk markers? ICD THERAPIES: are they harmful or just high risk markers? Konstantinos P. Letsas, MD, PhD, FESC LAB OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL ATHENS ICD therapies are common In a meta-analysis

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for Predisposition to Inherited Hypertrophic File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_predisposition_to_inherited_hypertrophic_cardiomyopathy

More information

at least 4 8 hours per week

at least 4 8 hours per week ECG IN ATHLETS An athlete is defined as an individual who engages in regular exercise or training for sport or general fitness, typically with a premium on performance, and often engaged in individual

More information

What Every Physician Should Know:

What Every Physician Should Know: What Every Physician Should Know: The Canadian Heart Rhythm Society estimates that, in Canada, sudden cardiac death (SCD) is responsible for about 40,000 deaths annually; more than AIDS, breast cancer

More information

Adult Complexities of the Channelopathies

Adult Complexities of the Channelopathies Adult Complexities of the Channelopathies Andrew Krahn MD FHRS Sauder Family and Heart and Stroke Foundation Chair in Cardiology Paul Brunes Chair in Heart Rhythm Disorders University of British Columbia

More information

Defibrillation threshold testing should no longer be performed: contra

Defibrillation threshold testing should no longer be performed: contra Defibrillation threshold testing should no longer be performed: contra Andreas Goette St. Vincenz-Hospital Paderborn Dept. of Cardiology and Intensive Care Medicine Germany No conflict of interest to disclose

More information

Invasive Risk Stratification: When is it needed?

Invasive Risk Stratification: When is it needed? Inherited Cardiomyopathies and Channelopathies: Who is at risk for Sudden Cardiac Death? Invasive Risk Stratification: When is it needed? Hung-Fat Tse, MD, PhD Department of Medicine The University of

More information

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes RHEA C. PIMENTEL, MD, FACC, FHRS UNIVERSITY OF KANSAS HOSPITAL MID AMERICA CARDIOLOGY AUGUST 19, 2012 Monogenic Arrhythmia Syndromes Mendelian

More information

Preventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete

Preventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete Preventing Sudden Death in Young Athletes Ronn E. Tanel, MD Director, Pediatric Arrhythmia Service UCSF Children s Hospital Associate Professor of Pediatrics UCSF School of Medicine Outline Sudden death

More information

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015 Steel vs Alcohol Or Neither Management of Hypertrophic Cardiomyopathy Josh Doll, MD January 24, 2015 47yo Male, Mr. L Severe progressive dyspnea on exertion and weight gain Previous avid Cross-Fit participant

More information

Sports Cardiology: Matters of the Heart. AMSSM Exchange Lecture AOSSM 2013 Annual Meeting

Sports Cardiology: Matters of the Heart. AMSSM Exchange Lecture AOSSM 2013 Annual Meeting Sports Cardiology: Matters of the Heart AMSSM Exchange Lecture AOSSM 2013 Annual Meeting Matthew Gammons, MD Vermont Orthopaedic Clinic Killington Medical Clinic Although sudden cardiac death is a relatively

More information

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation

More information

JOHNS HOPKINS ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY PROGRAM

JOHNS HOPKINS ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY PROGRAM JOHNS HOPKINS ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY PROGRAM Volume 5, 9, Issue 1 Winter Winter 2019 2015 * ** ***!!!HAPPY NEW YEAR!!!*** ** * From all of us here at the ARVD/C Program,

More information

UnitedHealthcare Medicare Advantage Cardiology Prior Authorization Program

UnitedHealthcare Medicare Advantage Cardiology Prior Authorization Program Electrophysiology Implant Classification Table The table below contains the codes that apply to our UnitedHealthcare Medicare Advantage cardiology prior Description Includes Generator Placement Includes

More information

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11 Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias Markus Kowalsky Group 11 Selected Paper Ventricular arrhythmia is predicted by sum absolute QRST integral but not

More information

Echocardiography for the Electrophysiologist: Day-to-day practice. Emmanuel Fares, MD

Echocardiography for the Electrophysiologist: Day-to-day practice. Emmanuel Fares, MD Echocardiography for the Electrophysiologist: Day-to-day practice Emmanuel Fares, MD EP and pacing service, Department of Cardiovascular Medicine, Cairo University Agenda Role of echo in arrhythmia management:

More information

Surviving Sudden Cardiac Arrest: A Pilot Survey

Surviving Sudden Cardiac Arrest: A Pilot Survey Surviving Sudden Cardiac Arrest: A Pilot Survey Take Heart America October 21, 2016 Mary M. Newman, MS sca-aware.org We were saved by CPR, an AED and someone like you! Surviving Sudden Cardiac Arrest:

More information

YES NO UNKNOWN. Stage I: Rule-Out Dashboard Secondary Findings in Adults ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS

YES NO UNKNOWN. Stage I: Rule-Out Dashboard Secondary Findings in Adults ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS Stage I: Rule-Out Dashboard HGNC ID: 11949, 6636, 2928 OMIM ID: 191045, 150330, 302045 ACTIONABILITY PENETRANCE 1. Is there a qualifying resource, such as a practice guideline or systematic review, for

More information

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program: Notification and Prior Authorization Program: Electrophysiology Implant Classification Table The following chart contains the codes that require notification or prior authorization as part of UnitedHealthcare

More information

Underwriting Inherited or Acquired Cardiomyopathies

Underwriting Inherited or Acquired Cardiomyopathies 19 Underwriting Inherited or Acquired Cardiomyopathies Andrea Di Lenarda, Patrizia Marocco, Giulia Barbati *, Marco Merlo*, Marco Anzini*, Andrea Perkan*, Francesca Cettolo*, Bruno Pinamonti*, Gianfranco

More information

Clinical Policy Title: Genetic testing for hereditary cardiomyopathy

Clinical Policy Title: Genetic testing for hereditary cardiomyopathy Clinical Policy Title: Genetic testing for hereditary cardiomyopathy Clinical Policy Number: 02.01.21 Effective Date: October 1, 2016 Initial Review Date: August 17, 2016 Most Recent Review Date: August

More information

CURRICULUM GOALS AND OBJECTIVES CLINICAL CARDIOVASCULAR ELECTROPHYSIOLOGY TRAINING PROGRAM. University of Florida Gainesville, Florida

CURRICULUM GOALS AND OBJECTIVES CLINICAL CARDIOVASCULAR ELECTROPHYSIOLOGY TRAINING PROGRAM. University of Florida Gainesville, Florida CURRICULUM GOALS AND OBJECTIVES CLINICAL CARDIOVASCULAR ELECTROPHYSIOLOGY TRAINING PROGRAM University of Florida Gainesville, Florida 1. Mission Statement To achieve excellence in the training of fourth

More information

Interpretation and Consequences of Repolarisation Changes in Athletes

Interpretation and Consequences of Repolarisation Changes in Athletes Interpretation and Consequences of Repolarisation Changes in Athletes Professor Sanjay Sharma E-mail sasharma@sgul.ac.uk @SSharmacardio Disclosures: None Athlete s ECG Vagotonia Sinus bradycardia Sinus

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: April 21, 2017 Number: MG.MM.DM.10dC3v4 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Stressors that Contribute to Emergency Service Use in Persons with IDD and Mental Health Needs

Stressors that Contribute to Emergency Service Use in Persons with IDD and Mental Health Needs Stressors that Contribute to Emergency Service Use in Persons with IDD and Mental Health Needs Joan B. Beasley, Ph.D. Research Associate Professor Director, Center for START Services University of New

More information

Tachycardia Devices Indications and Basic Trouble Shooting

Tachycardia Devices Indications and Basic Trouble Shooting Tachycardia Devices Indications and Basic Trouble Shooting Peter A. Brady, MD., FRCP Cardiology Review Course London, March 6 th, 2014 2011 MFMER 3134946-1 Tachycardia Devices ICD Indications Primary and

More information

Inherited Arrhythmia Syndromes

Inherited Arrhythmia Syndromes Inherited Arrhythmia Syndromes When to perform Genetic testing? Arthur AM Wilde February 4, 2017 Which pts should undergo genetic testing? SCD victims with a likely diagnosis Pts diagnosed with an inherited

More information

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden

More information

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

La valutazione dell atleta: è una strategia salva-vita e costo-efficace? La valutazione dell atleta: è una strategia salva-vita e costo-efficace? Primo trattato di Medicina Wilson and Jungner s criteria In the 1960s the World Health Organization adopted the Wilson and Jungner

More information

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Hanne Rasmusen Consultant cardiologist, PhD Dept. of Cardiology Bispebjerg University Hospital

More information

Body image concerns in patients with an implantable cardioverter defibrillator: A scoping review

Body image concerns in patients with an implantable cardioverter defibrillator: A scoping review Syddansk Universitet Body image concerns in patients with an implantable cardioverter defibrillator: A scoping review Frydensberg, Vivi; Skovbakke, Søren Jensen; Pedersen, Susanne S.; Kok, Robin Niels

More information

Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death

Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death A subcutaneous

More information

Prevention of Sudden Death in ARVC

Prevention of Sudden Death in ARVC ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück

More information

Name of Presenter: Marwan Refaat, MD

Name of Presenter: Marwan Refaat, MD NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 I have no actual or potential conflict of interest in relation

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

Sudden cardiac death: Primary and secondary prevention

Sudden cardiac death: Primary and secondary prevention Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)

More information

PACES Research Meeting May 12, Boston, MA. Introduction

PACES Research Meeting May 12, Boston, MA. Introduction PACES Research Meeting May 12, 2015 Boston, MA Introduction On Tuesday May 12 before the annual PACES symposium, a research meeting was held. This was sponsored by Johnson and Johnson. This meeting represents

More information

Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD

Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD Professor of Cardiology/Medicine Director of the Heart Research Follow Up Program, University of Rochester, Rochester,

More information

HYPERTROPHIC CARDIOMYOPATHY

HYPERTROPHIC CARDIOMYOPATHY HYPERTROPHIC CARDIOMYOPATHY Most often diagnosed during infancy or adolescence, hypertrophic cardiomyopathy (HCM) is the second most common form of heart muscle disease, is usually genetically transmitted,

More information

Clinical Policy Title: Genetic testing for hereditary cardiomyopathy

Clinical Policy Title: Genetic testing for hereditary cardiomyopathy Clinical Policy Title: Genetic testing for hereditary cardiomyopathy Clinical Policy Number: 02.01.24 Effective Date: October 1, 2016 Initial Review Date: August 17, 2016 Most Recent Review Date: August

More information

Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In?

Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In? Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In? 24 th Annual San Diego Heart Failure Symposium June 1-2, 2018 La Jolla, CA Barry Greenberg, MD Distinguished Professor of Medicine Director,

More information

Family-centered Stress Management for Childhood Cancer: A Multimodal Intervention for Children Newly Diagnosed with Cancer and their Families

Family-centered Stress Management for Childhood Cancer: A Multimodal Intervention for Children Newly Diagnosed with Cancer and their Families Family-centered Stress Management for Childhood Cancer: A Multimodal Intervention for Children Newly Diagnosed with Cancer and their Families Linda Ewing, Ph.D., RN Department of Psychiatry University

More information

OHTAC Recommendation: Internet- Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices

OHTAC Recommendation: Internet- Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices OHTAC Recommendation: Internet- Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices Ontario Health Technology Advisory Committee January 2012 Issue Background The Ontario

More information

Genotype Positive/ Phenotype Negative: Is It a Disease?

Genotype Positive/ Phenotype Negative: Is It a Disease? Genotype Positive/ Phenotype Negative: Is It a Disease? Michelle Michels MD, PhD Center of Inherited Cardiovascular Diseases Erasmus MC, Rotterdam, the Netherlands No disclosures What is phenotype negative

More information

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος Dr. Konstantinou

More information

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) D. D. MANOLATOS, MD, PhD, FESC Electrophysiology and Device Lab General Hospital Evangelismos, Athens The Problem: 300,000 people die each year

More information

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol Clinical Features FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol History: Progressive disease, characterised by the following clinical stages: o Early concealed phase

More information

Sudden Cardiac Death and Asians Disclosures

Sudden Cardiac Death and Asians Disclosures Sudden Cardiac Death and Asians Disclosures 7 February 2009 Asian Heart and Vascular Symposium None Zian H. Tseng, M.D., M.A.S. Assistant Professor of Medicine Cardiac Electrophysiology Section University

More information

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS

More information

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death Cardiac Conditions in Sport & Exercise Dr Anita Green Cardiac Conditions in Sport Sudden Cardiac Death USA - Sudden Cardiac Death (SCD)

More information

Strength and weakness of genetic testing in clinical routine.

Strength and weakness of genetic testing in clinical routine. Strength and weakness of genetic testing in clinical routine. Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular

More information

Sudden death and inherited heart disease: a national plan. Dr Paul Brennan Lead Consultant in Cardiac Genetics Northern Genetics Service, UK

Sudden death and inherited heart disease: a national plan. Dr Paul Brennan Lead Consultant in Cardiac Genetics Northern Genetics Service, UK Sudden death and inherited heart disease: a national plan Dr Paul Brennan Lead Consultant in Cardiac Genetics Northern Genetics Service, UK Coronary Heart Disease National Service Framework Chapter Eight

More information

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation? Innovations in Interventional Cardiology and Electrophysiology Thessaloniki 2014 Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation? K. Letsas, MD, FESC

More information

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine Jens Bremerich Radiology University Hospital Basel Hypertrophic Obstructive Cine VENC Cine (5m/s) Modified Bernoulli Equation: P (in mmhg) = 4 x (Vmax)2 Vmax= 4.2 m/s, P = 70mm Hg Hydrodynamica 738 HOCM

More information

Family stories: to illustrate inheritance and the impact on families. Dr Claire Turner Consultant clinical geneticist

Family stories: to illustrate inheritance and the impact on families. Dr Claire Turner Consultant clinical geneticist Family stories: to illustrate inheritance and the impact on families Dr Claire Turner Consultant clinical geneticist Overview With respect to inherited cardiac conditions Simple modes of inheritance (Mendelian)

More information